Sources | Names Used |
---|---|
CTRPv2 | navitoclax:MST-312 (1:1 mol/mol) |
PharmacoGx | navitoclax:MST-312 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SSH3 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-05 |
mRNA | MCCC2 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | LGALS3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
mRNA | RAB1A | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
mRNA | CTNND1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
mRNA | MST1R | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |
mRNA | EVPL | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | CLCN2 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | ETFA | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |